Ashwani Verma Stock Analyst Profile - UBS Research Coverage - Stocknear

Ashwani Verma

Stock Analyst at UBS

(4.67)
# 1373
Out of 5,506 analysts
97
Total ratings
Success rate
Average return

24 Stocks

Name Action PT Current % Upside Ratings Updated
UTHR United Therapeutics
Maintains: Strong Buy
560 580
453.07 28.02% 8 Sep 29, 2025
TEVA Teva Pharmaceutical ...
Maintains: Strong Buy
23 26
20 30% 10 Sep 24, 2025
BHVN Biohaven
Maintains: Buy
27 26
15.81 64.45% 4 Sep 16, 2025
ACAD ACADIA Pharmaceutica...
Maintains: Strong Buy
36 39
21.8 78.9% 7 Sep 9, 2025
AVDL Avadel Pharmaceutica...
Maintains: Strong Buy
13 20
15.01 33.24% 3 Aug 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
133 144
120.3 19.7% 5 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
43 38
40.09 -5.21% 4 Jul 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
17 18
16.9 6.51% 1 Jul 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
152 174
137.03 26.98% 9 Jul 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 54
32.06 68.43% 3 Jul 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
33 42
31.06 35.22% 5 Jun 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
61 61
86.85 -29.76% 1 Jun 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
47 41
56.97 -28.03% 5 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
55 48
27.28 75.95% 2 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 2
1.64 -35.98% 5 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
145 179
139.48 28.33% 6 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
106 114
85.07 34.01% 2 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
83 79
n/a n/a 5 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
28
36.07 -22.37% 3 Jun 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
11 7
113.62 -93.84% 1 Aug 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
209
n/a n/a 2 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
9 12
10.19 17.76% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
0.51 2841.18% 1 Oct 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
137 71
n/a n/a 3 Aug 4, 2022